Coronavirus - Ethiopia: The United States Announces Donation of 453,600 Doses of the Johnson & Johnson COVID-19 Vaccine to Ethiopia

  

U.S. Embassy Addis Ababa, Ethiopia


The U.S. Embassy in Addis Ababa, Ethiopia announces the donation by the United States Government of 453,600 doses of the Johnson&Johnson COVID-19 vaccine as part of the U.S. government’s global efforts to fight the COVID-19 pandemic.  The donated vaccines are part of the U.S. pledge to initially provide 25 million doses to Africa of 80 million doses globally.  The U.S. government coordinated closely with the African Union and Africa CDC on the country allocations.   The vaccine doses arrived via COVAX in Addis Ababa, Ethiopia on Monday, July 19, 2021. This donation will help protect the Ethiopian people from the ravages of the COVID-19 virus and begin reducing barriers to building back Ethiopia’s economy.

“Ventilators, medicine, test kits, oxygen concentrators, personal protective equipment….and today, we are proud to add “vaccines” to the list of support that the American people are providing Ethiopia to save lives in the fight against COVID-19,” said Ambassador Geeta Pasi.

These 453,600 doses are part of the U.S. commitment to share the U.S. vaccine supply to the world. We continue to fight the COVID-19 pandemic at home and work to end the pandemic worldwide, and as President Biden has said, the United States will serve as an arsenal of vaccines for the world. We firmly believe that, working together, we can defeat COVID-19.

“From the beginning of my presidency, we have been clear-eyed that we need to attack this virus globally as well. This is about our responsibility — our humanitarian obligation to save as many lives as we can — and our responsibility to our values. We’re going to help lead the world out of this pandemic, working alongside our global partners.” — President Biden

Distributed by APO Group on behalf of U.S. Embassy Addis Ababa, Ethiopia.

Send us your press releases to pressrelease.zawya@refinitiv.com


© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.


More From Press Releases